astragaloside a has been researched along with mocetinostat in 4 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (mocetinostat) | Trials (mocetinostat) | Recent Studies (post-2010) (mocetinostat) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 21,735 | 390 | 8,606 |
| Protein | Taxonomy | astragaloside a (IC50) | mocetinostat (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.7851 | |
| Nuclear receptor corepressor 1 | Homo sapiens (human) | 0.022 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.57 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.102 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.102 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.3433 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.3537 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.6386 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.6725 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.5717 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.6725 | |
| Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Fan, Y; Hu, G; Jia, R; Ma, X; Qiu, L; Sun, R; Tang, M; Wang, X; Xiao, W; Xing, M; Yin, G; Yu, G; Zhao, Y | 1 |
| Frei, B; Zhang, WJ | 1 |
| Chen, T; Ji, H; Jiang, W; Lu, G; Ma, Z; Ren, Y; Song, Y; Wang, H; Wang, R; Xu, A; Xu, Y; Yong, S | 1 |
| Dai, R; Fang, Z; Huang, K; Qin, S; Yin, J | 1 |
4 other study(ies) available for astragaloside a and mocetinostat
| Article | Year |
|---|---|
Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB.
Topics: Amylases; Animals; Antioxidants; Cytokines; Disease Models, Animal; Enzyme Activation; Inflammation Mediators; Lipase; Male; Necrosis; NF-kappa B; Pancreatitis; Peroxidase; Protein Transport; Rats; Saponins; Triterpenes | 2015 |
Astragaloside IV inhibits NF- κ B activation and inflammatory gene expression in LPS-treated mice.
Topics: Animals; Astragalus propinquus; Chemokine CCL2; Female; Inflammation; Interleukin-6; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Myocardium; NF-kappa B; Peroxidase; Saponins; Signal Transduction; Tissue Distribution; Toll-Like Receptor 4; Transcription Factor AP-1; Triterpenes; Tumor Necrosis Factor-alpha | 2015 |
Protective Effect of Astragaloside IV Against Paraquat-Induced Lung Injury in Mice by Suppressing Rho Signaling.
Topics: Acute Lung Injury; Animals; Antioxidants; Bronchoalveolar Lavage Fluid; Catalase; Drugs, Chinese Herbal; Enzyme Activation; Glutathione Peroxidase; Interleukin-6; Lung; Malondialdehyde; Mice; Mice, Inbred BALB C; NF-kappa B; Oxidative Stress; Paraquat; Peroxidase; Random Allocation; rho GTP-Binding Proteins; rho-Associated Kinases; Saponins; Signal Transduction; Superoxide Dismutase; Thioredoxins; Triterpenes; Tumor Necrosis Factor-alpha | 2016 |
The effect of Astragaloside IV on ethanol-induced gastric mucosal injury in rats: Involvement of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Disease Models, Animal; Ethanol; Gastritis; Humans; Inflammation Mediators; Intestines; Male; Neutrophils; NF-kappa B; Omeprazole; Peroxidase; Rats; Rats, Sprague-Dawley; Saponins; TNF Receptor-Associated Factor 2; Triterpenes; Tumor Necrosis Factor-alpha | 2017 |